Regeneron Pharmaceuticals Inc. buy Luise1
Start price
21.06.15
/
50%
€463.80
Target price
21.12.15
€550.50
Performance (%)
9.26%
End price
21.12.15
€506.77
Summary
This prediction ended on 21.12.15 with a price of €506.77. The BUY prediction by Luise1 finished with a performance of 9.26%. Luise1 has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 0.377% | 0.377% | -7.342% | -6.446% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% | 70.602% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% | 103.322% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% | 44.593% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% | 64.741% |
Comments by Luise1 for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Biotech
ein spekulatives buy
(Laufzeit überschritten)